Trial Profile
Perfluorocarbon (ABL-101) Oxygenation for Stroke: Trial With GOLD (Glasgow Oxygen Level Dependent Technology) Imaging Theranostic (POST-IT)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxycyte (Primary) ; Oxygen
- Indications Stroke
- Focus Adverse reactions
- Acronyms POST-IT
- 01 Aug 2018 Planned initiation date changed from 1 Mar 2018 to 1 Sep 2018.
- 19 Mar 2018 New trial record